BAMCO Inc
LEGN icon

BAMCO Inc’s Legend Biotech LEGN Stock Holding History

BAMCO Inc’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-168,158
Closed -$8.19M – 330
2024
Q3 		$8.19M Sell
168,158
-141,106
-46% -$7.52M 0.02% 244
2024
Q2 		$13.7M Buy
309,264
+32,437
+12% +$1.5M 0.04% 227
2024
Q1 		$15.5M Buy
276,827
+97,259
+54% +$5.87M 0.04% 220
2023
Q4 		$10.8M Buy
179,568
+22,368
+14% +$1.42M 0.03% 231
2023
Q3 		$10.6M Buy
157,200
+91,500
+139% +$6.36M 0.03% 232
2023
Q2 		$4.54M Buy
65,700
+25,700
+64% +$1.68M 0.01% 265
2023
Q1 		$1.93M Buy
40,000
+4,000
+11% +$196K 0.01% 301
2022
Q4 		$1.8M Buy
+36,000
New +$1.74M 0.01% 315

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BAMCO Inc's LEGN Position: Q4 2024 in Review

BAMCO Inc sold out of Legend Biotech (LEGN) in Q4 2024, closing a stake of 168,158 shares — an estimated $8.19M sold.

BAMCO Inc first reported a position in LEGN in Q4 2022 and held it in 8 quarters. The position peaked at $15.5M in Q1 2024. 211 funds tracked by Wall St. Rank hold LEGN as of Q4 2024.

  • BAMCO Inc reported no remaining Legend Biotech position as of Q4 2024 after selling out during the quarter.
  • BAMCO Inc sold 168,158 Legend Biotech shares in Q4 2024, an estimated $8.19M.
  • BAMCO Inc first reported a position in Legend Biotech in Q4 2022 and held it in 8 quarters.
  • BAMCO Inc's Legend Biotech position peaked at $15.5M in Q1 2024.
  • 211 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2024.

Based on BAMCO Inc's 13F filing for Q4 2024, filed 14 Feb 2025.